(8 years, 8 months ago)
Commons ChamberIn my view, real progress has been made, culminating in January 2016 with the Under-Secretary of State for Health, the hon. Member for Battersea (Jane Ellison), outlining an additional £100 million, with principles laid out as part of the consultation.
As the Minister knows. I have followed this issue incredibly closely during my time in the House. It has been raised with me repeatedly by my constituent and victim Steve Dymond—the Minister is familiar with his case. Another constituent, Mr Lee Stay, has made himself known to me, and I am here to speak for him too. In the 1980s, he attended the Lord Mayor Treloar college in Hampshire, which was a specialist boarding school with a wing for haemophiliac children. He was given factor VIII, but the blood products contained HIV and hep C. He had a liver transplant, and now suffers from Burkitt lymphoma. He cannot work, and his house has been repossessed.
I know rather more about Mr Dymond, who is a tireless campaigner and advocate for his fellow victims. He has not been able to attend today. He is extremely unwell as a result of his hepatitis C infection, but I know that he will be watching and that the whole House will wish him and all the victims we have heard about today recovery where at all possible. Steve Dymond was afflicted by hepatitis C through no fault of his own, having received contaminated blood as treatment for haemophilia, as we have heard from many cases this afternoon. Every day of Steve’s life since his infection has been lived through the lens of that condition. His capacity to work, to enjoy time with his family, to travel, to holiday and to do all those normal things that we take for granted has been fundamentally affected by his infection.
My hon. Friend refers to family. I want to raise the case of a constituent of mine, which I had the opportunity to talk about when we last discussed this matter in July 2015. My constituent, who was affected by contaminated blood, was trying to have a child through IVF. The couple were entitled to one round of IVF through the normal procedures, but they applied for a second round. Despite the fact that their fertility was affected by contaminated blood, they were denied a second round of IVF and had to spend £8,000 of their family money in order to conceive a second child, who has just been born, to their delight. Does my hon. Friend agree that, in the context of family and support, it is extraordinary that my constituent had to go through such hardship to extend his family?
I entirely agree and thank my hon. Friend for his comments. That example highlights the issues faced not only by the victim, but by the family from young to old. It is remarkable that special cases such as he describes are not recognised by the system. I hope that as part of the review those instances will be resolved.
What happened to Steve, Lee and all the others whom we have heard about today was wrong. In many cases it was avoidable. They were blameless victims who were handed debilitating, dehumanising—as my hon. Friend’s example shows—and degenerative infections that have caused heartache to all those affected. Although responsibility obviously lies with the commercial suppliers of the products, the NHS unwittingly administered them, and society owes the victims a debt. We must do the best we can to alleviate the pain and illness that victims have suffered. The decision that this House and the Government take should place those victims front and centre.
There are two threads to the approach that we should take. First, we must provide treatment for the victims, who suffer from various complex conditions and symptoms that require advanced and expensive care. It is right that we invest in the care and treatment available for those conditions, and in research. Thankfully, medical advances are making rapid progress. Secondly, we must ensure that as much restitution as possible is made to those who have suffered in that way.